Singapore, May 8 -- The Health Sciences Authority received information related to the study titled 'Effect of innate immune reprogramming by primary dengue on host response to secondary dengue'. The following are the other relevant details related to the trial:
Therapeutic Area: Infectious Diseases
Trial Centre(s):
Singapore General Hospital
Trial Status: NA
Principal Investigator(s):
Dr Jenny Low
Published by HT Digital Content Services with permission from Health Daily Digest....